Explaining And Predicting The Single Channel Versus Multi-Channel Consumer: The Case Of An Embarrassing Product

This study found that while the over-the-counter market for minoxidil hair loss products is expanding, only 25% of these products report safety information, and none report adverse effects, highlighting a need for greater transparency and accuracy in their advertising.

This article illustrates the impact of direct-to-consumer drug advertising through a case where a patient sought Rogaine for hair loss without medical assessment, revealing secondary syphilis-related symptoms instead.

This article discusses a forthcoming advertising campaign for minoxidil, highlighting the need for dermatologists to understand its efficacy, with reports showing it was significantly superior to placebo in promoting hair growth at four months.

This article explores how YouTube videos of men using Minoxidil and Finasteride for hair growth redefine traditional roles of health experts and patients, offering a model applicable to various self-tracking communities.

Topical minoxidil may slow hair loss but often doesn't lead to satisfactory hair regrowth and requires ongoing treatment.